Published Date: 10 Mar 2023
According to a recent report by the World Economic Forum, global factors such as the rising cost of living, the COVID-19 pandemic and climate change...
Read Full NewsA 46-year-old woman developed disseminated sarcoidosis after an eyebrow tattoo, with lesions spreading to distant, nontattooed skin and bilateral hilar nodes.
The AVANT GUARD trial design stacked the odds in favor of PFA over antiarrhythmic drugs. Yet, the results are unconvincing to this electrophysiologist. Maybe not all PFA systems are created equal.
Corticosteroids are associated with reduced cough severity and improved cough-related quality of life in patients with hypersensitivity pneumonitis, but they do not reduce objective cough frequency.
Dr Anne Peters discusses the varying subtypes of diabetes.
Cardiologists Bob Harrington and Lisa Rosenbaum discuss the loss of trust in medicine, how it may reflect patients’ desire for agency, and strategies to earn it back.
A 20-year-old man on daily finasteride suffers an ischemic stroke with multifocal carotid stenoses and multiple prothrombotic genetic variants — could the drug be implicated?
Medical specialties in which most doctors think they have either a promising or grim near-term (next 3 years) future are revealed.
1.
Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopenia
2.
Chronic pain and poor sleep are troublesome bed partners.
3.
Study offers clearer picture of childhood brain tumor survival
4.
Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.
5.
In 18 States, alcohol exclusion laws are still in effect.
1.
Oncology Treatment: Innovations, Education, and Clinical Practice Insights
2.
The Significance of APTT Blood Test Results for Detecting Coagulation Disorders
3.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
4.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
5.
The Essential Guide to Understanding Fibrinogen and Its Role in Blood Clotting
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
4.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
5.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation